Antiphospholipid Syndrome Clinical Trials

97 clinical trials for Antiphospholipid Syndrome across international registries, including 34 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort Study — RECRUITING · NA
• Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome — RECRUITING
• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — RECRUITING · PHASE1
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) — RECRUITING · PHASE1
• Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial) — RECRUITING · PHASE2
• Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome — RECRUITING
• Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome — RECRUITING
• International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants — RECRUITING
• Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) — RECRUITING
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases — RECRUITING · PHASE1
• Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• Rheumatology Patient Registry and Biorepository — RECRUITING
• Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients — RECRUITING
• Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases — RECRUITING · NA
• Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS — RECRUITING
• Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study — RECRUITING
• Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS) — RECRUITING · NA
• Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome — RECRUITING · NA
• Follow-up Cohort of Patients With Antiphospholipid Syndrome — RECRUITING
• Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Anti-CD38 Antibody Treating APS With Thrombocytopenia — RECRUITING · PHASE2
• A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases — RECRUITING · PHASE1
• Negative Antiphospholipid Syndrome: a Multicentric Study — RECRUITING
• BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases — RECRUITING · PHASE2
• Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia — RECRUITING · PHASE2
• Effect of Belimumab on Antibody Titers in Primary APS Patients — RECRUITING · PHASE2
• Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases — RECRUITING · NA
• Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE — RECRUITING · PHASE4
• An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease — RECRUITING · NA
• New Biological Tests in Patients With Antiphospholipid Antibodies — RECRUITING
• Laboratory and Clinical Data in Antiphospholipid Patients — RECRUITING
• Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research — NOT_YET_RECRUITING
• Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device — COMPLETED · NA
• A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis — ACTIVE_NOT_RECRUITING · PHASE1
• RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome — COMPLETED · PHASE2
• Point of Care Testing INR in Antiphospholipid Syndrome — NOT_YET_RECRUITING · NA
• Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome — TERMINATED · PHASE2
• Pregnancy and Medically Assisted Conception in Rare Diseases — WITHDRAWN
• A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS) — WITHDRAWN · PHASE2
• YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter — COMPLETED · NA
• Effect of Telitacicept on Antibody Titers in Primary APS Patients — COMPLETED · PHASE2
• Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases — NOT_YET_RECRUITING · NA
• Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies — NOT_YET_RECRUITING
• A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING EFFICACY, SAFETY, AND PHARMACOKINETICS OF CROVALIMAB IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) — NOT_YET_RECRUITING · PHASE2
• Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS) — COMPLETED

Refine this search